文献速递妇科产科

韩国全国队列:血清GGT升高与子宫内膜癌发病快速增加相关

Increasing serum gamma-glutamyltransferase level accompanies a rapid increase in the incidence of endometrial cancer in Korea: A nationwide cohort study.
PubMed 文献 · Gynecol Oncol · 2021-03-29

该研究基于韩国国民健康保险系统全国队列,纳入2009年参加健康筛查且检查后1年未诊断为子宫内膜癌的19岁以上女性2,736,588例,分析血清GGT水平与子宫内膜癌发病风险的关系。结果显示,肥胖女性中GGT升高与子宫内膜癌高风险相关(HR=1.415,95%CI:1.236-1.621),绝经前肥胖女性GGT最高四分位组风险亦升高(HR=1.482,95%CI:1.205-1.821),绝经后肥胖女性同样升高(HR=1.313,95%CI:1.096-1.573)。结论认为GGT升高是子宫内膜癌独立危险因素,尤其对绝经后女性和肥胖绝经前女性。

要点

  • 肥胖女性中血清GGT升高与子宫内膜癌风险升高相关(HR=1.415)。
  • 绝经前肥胖女性GGT最高四分位组风险升高(HR=1.482)。
  • 绝经后肥胖女性GGT最高四分位组风险亦升高(HR=1.313)。

核心结论

  • 血清GGT升高是子宫内膜癌的独立危险因素,尤其对绝经后女性和肥胖绝经前女性。
  • 血清GGT水平可能有助于子宫内膜癌的风险分层。
  • 建议通过健康生活方式降低血清GGT水平,尤其对子宫内膜癌高风险女性。

研究设计与样本

  • 韩国全国性队列研究,数据来自韩国国民健康保险服务(NHIS)医疗系统。
  • 纳入2009年参加韩国国民健康筛查、年龄大于19岁且检查后1年未诊断为子宫内膜癌的女性,共2,736,588例。

主要发现

  • 肥胖(BMI≥25 kg/m2)且GGT升高的女性子宫内膜癌风险升高(HR=1.415,95%CI:1.236-1.621)。
  • 绝经前女性中,仅肥胖者GGT最高四分位组(Q4)与子宫内膜癌风险升高相关(HR=1.482,95%CI:1.205-1.821)。
  • 绝经后女性中,仅肥胖者GGT最高四分位组(Q4)与子宫内膜癌风险升高相关(HR=1.313,95%CI:1.096-1.573)。
  • 绝经前腹型肥胖(WC≥85 cm)女性中,高GGT水平与子宫内膜癌风险升高显著相关(HR=1.647,95%CI:1.218-2.227)。

临床怎么用

  • 对肥胖女性可关注血清GGT水平,辅助子宫内膜癌风险分层。
  • 对绝经后及肥胖绝经前女性,建议通过健康生活方式降低血清GGT水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to determine the association of serum GGT levels with the risk of developing endometrial cancer. Women's obesity and menopausal status were also taken into account in our analysis. METHODS: We used a nationwide cohort to examine the association between serum GGT levels and endometrial cancer development in Korean women. Data were retrieved from the Korean National Health Insurance Service (NHIS) healthcare system. Women aged over 19 years who participated in the Korea National Health Screening Examination in 2009 and were not diagnosed with endometrial cancer 1-year post-examination were included in our study (n = 2,736,588). RESULTS: Obese (BMI, ≥25 kg/m2) women with increased GGT levels were at high risk of endometrial cancer (HR = 1.415, 95% CI: 1.236-1.621). Interestingly, in pre-menopausal women, high GGT level (Q4) was associated with the increased endometrial cancer risk only for obese women (HR = 1.482, 95% CI: 1.205-1.821). In post-menopausal women, only a high GGT level (Q4) was also associated with the increased cancer risk for obese women (HR = 1.313, 95% CI: 1.096-1.573). We observed a significant association between high GGT levels and increased risk of endometrial cancer in pre-menopausal women with abdominal obesity (WC, ≥85 cm) (HR = 1.647, 95% CI: 1.218-2.227). CONCLUSIONS: Increased GGT level is an independent risk factor of endometrial cancer, especially for post-menopausal women and obese pre-menopausal women. These results may suggest that serum GGT levels might be useful in the risk stratification of endometrial cancer. Adopting a healthy lifestyle for lowering serum GGT level is warranted, especially for women with a higher risk of developing endometrial cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Han Y, Park IS, Kim SI, et al. Increasing serum gamma-glutamyltransferase level accompanies a rapid increase in the incidence of endometrial cancer in Korea: A nationwide cohort study. Gynecol Oncol. 2021. PMID: 33795129. doi:10.1016/j.ygyno.2021.03.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。